Table 1. General characteristics and laboratory data of study groups.
| Group | p | |||
|---|---|---|---|---|
| Malignant nodule | Benign nodule | |||
| Gender | Men (n) | 24 | 23 | 0.96 |
| Women (n) | 77 | 75 | ||
| Mean ± SD | ||||
| WBC (K/mm3) | 6.9±1.7 | 7.2±1.9 | 0.13 | |
| Hb (g/dL) | 13.5±1.2 | 13.6±1.1 | 0.79 | |
| Htc (%) | 40±3.5 | 40.5±3 | 0.33 | |
| MCV (fL) | 86.8±3.7 | 87.3±4.2 | 0.34 | |
| PLT (K/mm3) | 249±63 | 260±58 | 0.19 | |
| MPV (fL) | 9.1±1 | 7.8±0.8 | <0.001 | |
| Median (min-max) | ||||
| Age (years) | 43 (25-77) | 45 (26-60) | 0.79 | |
| TSH (uIU/mL) | 1.21 (0.01-5.7) | 0.93 (0.01-4.4) | 0.60 | |
WBC = white blood cell count; Hb = hemoglobin; Htc = hematocrit; MCV = mean corpuscular volume; PLT = platelet count; MPV = mean platelet volume; TSH = thyroid stimulating hormone